Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: day (1000), time (1000)

People and OD Committee ToR September 2023

Description: People and Organisational Development Committee Terms of Reference Date Issued: 28 September 2023 Review Date: Septem
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/People-and-OD-Committee-ToR-September-2023.pdf

WDES annual report 2022

Description: Workforce Disability Equality Standard - Annual Report 2022 2 Executive Summary The Workforce Disability Equality Standard (WDES) i
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/Workforce-Disability-Equality-Standard-Annual-Report-2022.docx

People and OD Committee ToR December 2022

Description: Terms of Reference from a People and Organisational Development Committee.
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/People-and-OD-Committee-ToR-December-2022.pdf

Gastrointestinal (GI) late effects of cancer service - patient information

Description: This factsheet explains what our gastrointestinal (GI) late effects of cancer service is, what we offer and what happens next.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Gastrointestinal-GI-late-effects-of-cancer-service-3260-PIL.pdf

Tutorials - Top tips for referrals - issue 217 - Lymphadenopathy in Children Tutorial January 2022

Description: Tutorials: Top Tips for Referrals Issue 217 - Lymphadenopathy in Children January 2022 Background Many children have palpable lymph nodes whose relative
Url: /Media/UHS-website-2019/Docs/Services/Radiology/Tutorials-Top-tips-for-referrals-issue-217-Lymphadenopathy-in-Children-Tutorial-January-2022.pdf

UHS self-certification NHS provider licence conditions G6 and CoS7

Description: Worksheet "G6 & CoS7" Financial Year to which self-certification relates 2021/22 Please complete the explanatory information in cell Declarations required
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/NHS-Improvement-declaration-conditions-G6-and-CoS7.pdf

Total body irradiation (TBI) - patient information

Description: This factsheet explains what to expect at your TBI treatment appointments.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day Modified) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-Mod-BEP-Ver1.2.pdf

CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Ver 1.2

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE-PREDNISOLONE-VINCRISTINE Regimen (CEOP) Lymphoma – CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Indication Non-Hodgkin’s Lymphoma where
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine-Ver-1.2.pdf

ABVD – Bleomycin-Dacarbazine-Doxorubicin-Vinblastine Ver 1.2

Description: Chemotherapy Protocol LYMPHOMA BLEOMYCIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (ABVD) Regimen Lymphoma – ABVD-Bleomycin-Dacarb
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/ABVD-–-Bleomycin-Dacarbazine-Doxorubicin-Vinblastine-Ver-1.2.pdf

411 to 420 of 985

Previous … 40 41 42 43 44 … Next